Positive Phase 2b Results from the CAN-002 Study of PP-01, an investigational product intended to mitigate Cannabis Withdrawal Syndrome in patients with Cannabis Use Disorder PHOENIXVILLE, Pa., June ...

Drug treatments for cannabis use disorder remain limited but a new trial suggests an antismoking drug could help to reduce ...

January 31, 2008 — Cannabis withdrawal is clinically important and warrants inclusion in the Diagnostic and Statistical Manual (DSM), researchers argue in an article in the January 1 issue of Drug and ...

Emerging research reveals that people with substance use disorders (SUDs) may have increased pain sensitivity/hyperalgesia when withdrawing from addictive substances ...

To treat their pain, anxiety and sleep problems, millions of Americans turn to cannabis, which is now legal in 40 states for medical use. But a new review of 15 years of research concludes that the ...

As a millennial, I’ve seen the reputation of potheads elevate from burnouts buying incense and Grateful Dead shirts at the ...

PHOENIXVILLE, Pa., April 16, 2025 /PRNewswire/ -- PleoPharma, Inc. ("PleoPharma" or the "Company"), a privately held company focused on Cannabis-related health issues, announced today that the U.S.